Kohlberg Kravis Roberts & Co »

Travere Therapeutics shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 2.0M 1.13
2025-06-30 $778M 815k 955.02

More positions owned by Kohlberg Kravis Roberts & Co

Brightspring Health Svcs (BTSG)
Henry Schein (HSIC)
Bridgebio Pharma (BBIO)
Niq Global Intelligence Ordinary Shares
Paramount Skydance Corp Com Cl B (PSKY)
Brightview Holdings (BV)
Crescent Energy Company Cl A Com (CRGY)
Jetblue Airways Corp Note 0.500% 4/0 (Principal)
Kkr Real Estate Finance Trust (KREF)
Madison Square Grdn Sprt Cor Cl A (MSGS)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Bausch Health Companies (BHC)
Cable One Note 3/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Immunocore Hldgs Note 2.500% 2/0 (Principal)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Travere Therapeutics

Linden Advisors
D. E. Shaw & Co
Graham Capital Management
Advent Capital Management
Millennium Management
Lord, Abbett & Co
Point72 Asset Management
Oaktree Capital Management
Agf Management
Polar Capital Holdings
Affinity Asset Advisors
Henderson Group
Shenkman Capital Management
FMR
BlackRock

View all funds holding Travere Therapeutics